Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Recurrent Malignant Mesothelioma	NCIT_C7866	[The reemergence of malignant mesothelioma after a period of remission]
Recurrent Malignant Neoplasm	NCIT_C4813	[The reemergence of a malignant neoplasm after a period of remission.]
BRMS1 wt Allele	NCIT_C54393	[Human BRMS1 wild-type allele is located within 11q13-q13.2 and is approximately 8 kb in length. This allele, which encodes breast cancer metastasis-suppressor 1 protein, plays a role in metastasis suppression for both melanoma and breast cancer.]
BRMS1 Gene	NCIT_C20781	[This gene plays a role in metastasis suppression.]
Stage I Penile Cancer AJCC v6	NCIT_C7867	[Stage I includes: (T1, N0, M0). T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003]
Penile Cancer by AJCC v6 Stage	NCIT_C90520	[A term that refers to the staging of penile carcinoma according to the American Joint Committee on Cancer, 6th edition.]
PDCD1LG2 wt Allele	NCIT_C54394	[Human PDCD1LG2 wild-type allele is located in the vicinity of 9p24.2 and is approximately 60 kb in length. This allele, which encodes programmed cell death 1 ligand 2 protein, plays a role in the regulation of T-cell proliferation and cytokine expression.]
PDCD1LG2 Gene	NCIT_C45437	[This gene plays a role in the regulation of T-cell proliferation.]
Stage II Penile Cancer AJCC v6	NCIT_C7868	[Stage II includes: (T1, N1, M0); (T2, N0, M0); (T2, N1, M0). T1: Tumor invades subepithelial connective tissue. N0: No regional lymph node metastasis. N1: Metastasis in a single superficial, inguinal lymph node. M0: No distant metastasis. (AJCC 6th ed.) - 2003]
PDGFRL wt Allele	NCIT_C54395	[Human PDGFRL wild-type allele is located within 8p22-p21.3 and is approximately 66 kb in length. This allele, which encodes platelet-derived growth factor receptor-like protein, plays a putative role in the inhibition of cell growth and proliferation. Loss of PDGFRL gene function is associated with several types of cancer including colorectal cancers, hepatocellular carcinomas and non-small cell lung carcinomas.]
PDGFRL Gene	NCIT_C24668	[This gene may play a role in the negative regulation of cell growth.]
Localized Digestive System Neuroendocrine Tumor G1	NCIT_C7861	[A well differentiated neuroendocrine tumor (carcinoid tumor) that arises from the digestive system and is restricted to the site of origin without evidence of metastasis.]
Digestive System Neuroendocrine Tumor G1	NCIT_C7709	[A usually small, slow-growing, well differentiated neuroendocrine tumor arising from the digestive system. It is composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with small vesicular nuclei. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent. The tumor can occur anywhere in the digestive system; approximately 90% arise in the appendix.]
THOC5 wt Allele	NCIT_C54396	[Human THOC5 wild-type allele is located in the vicinity of 22q12.2 and is approximately 48 kb in length. This allele, which encodes THO complex subunit 5 homolog protein, may be involved in the regulation of messenger RNA transport.]
THOC5 Gene	NCIT_C21510	[This gene is involved in mRNA processing and transport.]
Regional Digestive System Neuroendocrine Tumor G1	NCIT_C7862	[A well differentiated neuroendocrine tumor (carcinoid tumor) that arises from the digestive system and has not spread to other regions.]
United States Pharmacopeia	NCIT_C54397	[The official public standards-setting authority for all prescription and over-the-counter medicines, dietary supplements, and other healthcare products manufactured and sold in the United States. USP sets standards for the quality of these products and works with healthcare providers to help them reach the standards. USP promotes the public health by developing and disseminating quality standards and information for medicines, healthcare delivery, and related products and practices. USP is an independent, science-based public health organization.]
Intent To Treat	NCIT_C54398	[The use of a particular medical device, medication or treatment to treat a pre-existing disease or condition.]
Medical Product Intent of Use	NCIT_C54390	[The objective intent of the persons legally responsible for the labeling of a medical product, which is determined by such persons' expressions or may be shown by the circumstances surrounding the distribution of the product.]
Recurrent Digestive System Neuroendocrine Tumor G1	NCIT_C7864	[A well differentiated neuroendocrine tumor (carcinoid tumor) that arises from the digestive system and has reemerged after a period of remission.]